Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Lilly Announces Major China R&D Center

publication date: Nov 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Eli Lilly will build a bricks and mortar center dedicated to R&D work on diabetes in Shanghai. The center represents a major strategic departure for Lilly, which has touted its partnership approach with China’s innovative life science community. Lilly says diabetes in China, which has reached epidemic proportions, has a different molecular structure than diabetes elsewhere in the world. The company hopes to discover innovative solutions to the disease. More details...

Stock Symbol: (NYSE: LLY)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners